Evidence map›Paper›PMID 28718892›Full record

ArticleBritish journal of pharmacology2017

Methoxetamine affects brain processing involved in emotional response in rats.

M T Zanda, P Fadda, S Antinori, M Di Chio, W Fratta, C Chiamulera, L Fattore

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. New psychoactive substances: a review and updates.Therapeutic advances in psychopharmacology · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

M T ZandaDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
P FaddaDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.ORCID http://orcid.org/0000-0002-0642-6710
S AntinoriDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
M Di ChioDepartment of Diagnostic and Public Health, Section of Pharmacology, University of Verona, Verona, Italy.
W FrattaDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
C ChiamuleraDepartment of Diagnostic and Public Health, Section of Pharmacology, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0001-5076-8518
L FattoreInstitute of Neuroscience (IN-CNR), National Research Council of Italy, Cagliari, Italy.ORCID http://orcid.org/0000-0002-2663-666X
University of Cagliari · ITUniversity of Verona · ITNeuroscience Institute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMethoxetamine (MXE) is a novel psychoactive substance that is emerging on the Internet and induces dissociative effects and acute toxicity. Its pharmacological effects have not yet been adequately investigated. EXPERIMENTAL APPROACH: We examined a range of behavioural effects induced by acute administration of MXE (0.5-5 mg·kg KEY

resultsMXE (0.5-5 mg·kg CONCLUSIONS AND IMPLICATIONS: MXE differentially affected motor activity, behaviour and emotional states in rats, depending on the dose tested. As reported for ketamine, phosphorylation of the ribosomal protein S6 was increased in MXE-treated animals, thus providing a 'molecular snapshot' of rapid neuroadaptive molecular changes induced by behaviourally active doses of MXE.

Indexed as

AnimalsAnxietyBehavior, AnimalBrainCyclohexanonesCyclohexylaminesEmotionsHot TemperatureIllicit DrugsLocomotionMaleObsessive BehaviorPsychotropic DrugsRatsRats, Sprague-DawleyRibosomal Protein S6 Kinases2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanoneCyclohexanonesCyclohexylaminesIllicit DrugsPsychotropic DrugsRibosomal Protein S6 Kinases

Identifiers

PMID28718892
PMCPMC5595753
OpenAlexW2738997352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.